Moreover, the 36-month beta value for SKIN is 1.23. Analysts have varying opinions on the stock, with 8 analysts rating it as a “buy,” 0 as “overweight,” 4 as “hold,” and 0 as “sell.”
The average price recommended by analysts for Beauty Health Company (SKIN) is $12.15, which is $7.54 above the current market price. The public float for SKIN is 87.74M and currently, short sellers hold a 26.00% of that float. On October 27, 2023, SKIN’s average trading volume was 2.26M shares.
The New Uranium Bull Market is here, and you’re right on time for the profit windfall. Don’t let inflation eat away your savings – invest in uranium stocks! We’ve uncovered THE ONE stock set to explode, drilling for uranium right here in the USA. This is your chance to get ahead of the herd. Grab our FREE report, featuring an exclusive CEO interview. Ready for the name and trading symbol?
SKIN) stock’s latest price update
Beauty Health Company (NASDAQ: SKIN)’s stock price has gone decline by -0.54 in comparison to its previous close of 4.64, however, the company has experienced a -6.58% decrease in its stock price over the last five trading days. MarketBeat reported 2023-09-26 that While the direction of the stock markets is unpredictable, the growth of the aging population is entirely predictable. Along with an aging population come additional healthcare, beauty and wellness needs.
SKIN’s Market Performance
Beauty Health Company (SKIN) has experienced a -6.58% fall in stock performance for the past week, with a -22.04% drop in the past month, and a -44.33% drop in the past quarter. The volatility ratio for the week is 5.61%, and the volatility levels for the past 30 days are at 5.57% for SKIN. The simple moving average for the past 20 days is -12.69% for SKIN’s stock, with a -50.02% simple moving average for the past 200 days.
Analysts’ Opinion of SKIN
Many brokerage firms have already submitted their reports for SKIN stocks, with Canaccord Genuity repeating the rating for SKIN by listing it as a “Buy.” The predicted price for SKIN in the upcoming period, according to Canaccord Genuity is $10 based on the research report published on August 25, 2023 of the current year 2023.
SKIN Trading at -20.17% from the 50-Day Moving Average
After a stumble in the market that brought SKIN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.80% of loss for the given period.
Volatility was left at 5.57%, however, over the last 30 days, the volatility rate increased by 5.61%, as shares sank -23.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.33% lower at present.
During the last 5 trading sessions, SKIN fell by -6.78%, which changed the moving average for the period of 200-days by -54.63% in comparison to the 20-day moving average, which settled at $5.22. In addition, Beauty Health Company saw -49.29% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SKIN starting from Miller Brian Christopher, who purchase 60,000 shares at the price of $5.81 back on Aug 17. After this action, Miller Brian Christopher now owns 91,450 shares of Beauty Health Company, valued at $348,600 using the latest closing price.
CAPELLAS MICHAEL D, the Director of Beauty Health Company, purchase 30,000 shares at $6.03 during a trade that took place back on Aug 17, which means that CAPELLAS MICHAEL D is holding 197,612 shares at $180,948 based on the most recent closing price.
Stock Fundamentals for SKIN
Current profitability levels for the company are sitting at:
- -0.83 for the present operating margin
- +66.78 for the gross margin
The net margin for Beauty Health Company stands at +12.13. The total capital return value is set at -0.31, while invested capital returns managed to touch 4.52. Equity return is now at value -5.82, with -1.35 for asset returns.
Based on Beauty Health Company (SKIN), the company’s capital structure generated 439.48 points at debt to equity in total, while total debt to capital is 81.46. Total debt to assets is 74.70, with long-term debt to equity ratio resting at 435.53. Finally, the long-term debt to capital ratio is 80.73.
When we switch over and look at the enterprise to sales, we see a ratio of 2.05, with the company’s debt to enterprise value settled at 0.49. The receivables turnover for the company is 5.66 and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.79.
Conclusion
To wrap up, the performance of Beauty Health Company (SKIN) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
